Novel insulin derivatives

Details for Australian Patent Application No. 2010200497 (hide)

International Classifications

Event Publications

25 February 2010 Complete Application Filed

4 March 2010 Application Open to Public Inspection

Published as AU-A-2010200497

16 February 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

12 April 2012 Section 223 Application Received

Novo Nordisk A/S An application to extend the time from 22 Jul 2011 to 22 Feb 2012 in which to pay the continuation fee has been filed . Address for service in Australia - Shelston IP Level 21 60 Margaret Street Sydney NSW 2000

31 May 2012 Section 223 Application Allowed

Novo Nordisk A/S The time in which to pay the continuation fee has been extended to 22 Feb 2012. Address for service in Australia - Shelston IP Level 21 60 Margaret Street Sydney NSW 2000

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.